Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T M de Reijke

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Urological Research|January 1, 1997
Intermittent androgen deprivation in advanced prostate cancerT M de Reijke
Urologia Internationalis|June 1, 2001
An unusual cause of irritable urinary bladder symptomsY Reisman, T M de Reijke
BJU International|March 31, 2004
Comparative efficacy of two alpha-adrenoreceptor antagonists, doxazosin and alfuzosin, in patients with lower urinary tract symptoms from benign prostatic enlargementT M de Reijke, P Klarskov
BJU International|November 18, 2003
Long-term complications of brachytherapy in local prostate cancerT M de Reijke, M Pilar Laguna
Urologia Internationalis|January 1, 1987
Adenocarcinoma of the kidney in childhoodT M de Reijke, T J Schlatmann, N F Dabhoiwala
The Journal of Urology|August 8, 2001
Local tract metastasis of prostatic adenocarcinoma 8 years after (125)iodine brachytherapyW J Wiersinga, T M De Reijke, L E Blank
British Journal of Cancer|January 26, 2000
Prostate cancer treated by anti-androgens: is sexual function preserved? EORTC Genitourinary Group. European Organization for Research and Treatment of CancerF H Schröder, L Collette, T M de Reijke, et al.
Seminars in Surgical Oncology|January 1, 1995
Incidental carcinoma of the prostateG van Andel, R Vleeming, K Kurth, et al.
Urological Research|January 1, 1992
BCG treatment and the importance of an inflammatory responseD H Schamhart, K H Kurth, T M de Reijke, et al.
World Journal of Urology|January 1, 1993
The detection of prostatic carcinoma. 4- or 7-MHz transrectal ultrasonography?R Vleeming, J W Noordzij, T M de Reijke, et al.
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Urological Research|January 1, 1997
Intermittent androgen deprivation in advanced prostate cancerT M de Reijke
Urologia Internationalis|June 1, 2001
An unusual cause of irritable urinary bladder symptomsY Reisman, T M de Reijke
BJU International|March 31, 2004
Comparative efficacy of two alpha-adrenoreceptor antagonists, doxazosin and alfuzosin, in patients with lower urinary tract symptoms from benign prostatic enlargementT M de Reijke, P Klarskov
BJU International|November 18, 2003
Long-term complications of brachytherapy in local prostate cancerT M de Reijke, M Pilar Laguna
Urologia Internationalis|January 1, 1987
Adenocarcinoma of the kidney in childhoodT M de Reijke, T J Schlatmann, N F Dabhoiwala
The Journal of Urology|August 8, 2001
Local tract metastasis of prostatic adenocarcinoma 8 years after (125)iodine brachytherapyW J Wiersinga, T M De Reijke, L E Blank
British Journal of Cancer|January 26, 2000
Prostate cancer treated by anti-androgens: is sexual function preserved? EORTC Genitourinary Group. European Organization for Research and Treatment of CancerF H Schröder, L Collette, T M de Reijke, et al.
Seminars in Surgical Oncology|January 1, 1995
Incidental carcinoma of the prostateG van Andel, R Vleeming, K Kurth, et al.
Urological Research|January 1, 1992
BCG treatment and the importance of an inflammatory responseD H Schamhart, K H Kurth, T M de Reijke, et al.
World Journal of Urology|January 1, 1993
The detection of prostatic carcinoma. 4- or 7-MHz transrectal ultrasonography?R Vleeming, J W Noordzij, T M de Reijke, et al.
Pageof 7